Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 390

1.

Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF.

Nicoletti F, Mazzon E, Fagone P, Mangano K, Mammana S, Cavalli E, Basile MS, Bramanti P, Scalabrino G, Lange A, Curtin F.

J Neuroimmunol. 2019 May 8;332:224-232. doi: 10.1016/j.jneuroim.2019.05.006. [Epub ahead of print]

PMID:
31100693
2.

Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma.

Paskaš S, Krajnović T, Basile MS, Dunđerović D, Cavalli E, Mangano K, Mammana S, Al-Abed Y, Nicoletti F, Mijatović S, Maksimović-Ivanić D.

Mol Carcinog. 2019 Apr 17. doi: 10.1002/mc.23020. [Epub ahead of print]

PMID:
30997718
3.

The neuropathic pain: An overview of the current treatment and future therapeutic approaches.

Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E.

Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419838383. doi: 10.1177/2058738419838383.

4.

Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia.

Nicoletti F, Orlando R, Di Menna L, Cannella M, Notartomaso S, Mascio G, Iacovelli L, Matrisciano F, Fazio F, Caraci F, Copani A, Battaglia G, Bruno V.

Front Psychiatry. 2019 Feb 14;10:49. doi: 10.3389/fpsyt.2019.00049. eCollection 2019. Review.

5.

Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis.

Curto M, Lionetto L, Fazio F, Corigliano V, Comparelli A, Ferracuti S, Simmaco M, Nicoletti F, Baldessarini RJ.

Schizophr Res. 2019 Mar 2. pii: S0920-9964(19)30080-5. doi: 10.1016/j.schres.2019.02.020. [Epub ahead of print] No abstract available.

PMID:
30837204
6.

Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status.

Celli R, Santolini I, Van Luijtelaar G, Ngomba RT, Bruno V, Nicoletti F.

Expert Opin Ther Targets. 2019 Apr;23(4):341-351. doi: 10.1080/14728222.2019.1586885. Epub 2019 Mar 21.

PMID:
30801204
7.

KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms.

Basile MS, Fagone P, Mangano K, Mammana S, Magro G, Salvatorelli L, Li Destri G, La Greca G, Nicoletti F, Puleo S, Pesce A.

Cancers (Basel). 2019 Feb 19;11(2). pii: E245. doi: 10.3390/cancers11020245.

8.

Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo.

Paskas S, Mazzon E, Basile MS, Cavalli E, Al-Abed Y, He M, Rakocevic S, Nicoletti F, Mijatovic S, Maksimovic-Ivanic D.

Invest New Drugs. 2019 Feb 1. doi: 10.1007/s10637-019-00733-3. [Epub ahead of print]

PMID:
30706336
9.

Differential modulation and prognostic values of immune-escape genes in uveal melanoma.

Basile MS, Mazzon E, Russo A, Mammana S, Longo A, Bonfiglio V, Fallico M, Caltabiano R, Fagone P, Nicoletti F, Avitabile T, Reibaldi M.

PLoS One. 2019 Jan 17;14(1):e0210276. doi: 10.1371/journal.pone.0210276. eCollection 2019.

10.

Epigenetic Alterations in Prenatal Stress Mice as an Endophenotype Model for Schizophrenia: Role of Metabotropic Glutamate 2/3 Receptors.

Matrisciano F, Dong E, Nicoletti F, Guidotti A.

Front Mol Neurosci. 2018 Nov 30;11:423. doi: 10.3389/fnmol.2018.00423. eCollection 2018. Review.

11.

Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?

Spampinato SF, Copani A, Nicoletti F, Sortino MA, Caraci F.

Front Mol Neurosci. 2018 Nov 13;11:414. doi: 10.3389/fnmol.2018.00414. eCollection 2018. Review.

12.

The H₂S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide.

Lazarević M, Mazzon E, Momčilović M, Basile MS, Colletti G, Petralia MC, Bramanti P, Nicoletti F, Miljković Đ.

Molecules. 2018 Nov 14;23(11). pii: E2966. doi: 10.3390/molecules23112966.

13.

Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets.

Günther S, Fagone P, Jalce G, Atanasov AG, Guignabert C, Nicoletti F.

Drug Discov Today. 2019 Feb;24(2):428-439. doi: 10.1016/j.drudis.2018.11.003. Epub 2018 Nov 13. Review.

PMID:
30439447
14.

Letter to the Editor Regarding: A Comprehensive Review on Copemyl®.

Comi G, Nicoletti F, Canonico PL, Centonze D.

Neurol Ther. 2018 Dec;7(2):385-390. doi: 10.1007/s40120-018-0115-y. Epub 2018 Nov 10. No abstract available.

15.

Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress.

Joffe ME, Santiago CI, Stansley BJ, Maksymetz J, Gogliotti RG, Engers JL, Nicoletti F, Lindsley CW, Conn PJ.

Neuropharmacology. 2019 Jan;144:19-28. doi: 10.1016/j.neuropharm.2018.10.013. Epub 2018 Oct 13.

PMID:
30326237
16.

Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain.

Zuena AR, Maftei D, Alemà GS, Dal Moro F, Lattanzi R, Casolini P, Nicoletti F.

Mol Pain. 2018 Jan-Dec;14:1744806918808987. doi: 10.1177/1744806918808987. Epub 2018 Oct 5.

17.

Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells.

Basile MS, Mazzon E, Krajnovic T, Draca D, Cavalli E, Al-Abed Y, Bramanti P, Nicoletti F, Mijatovic S, Maksimovic-Ivanic D.

Molecules. 2018 Sep 26;23(10). pii: E2463. doi: 10.3390/molecules23102463.

18.

Dickkopf-3 Causes Neuroprotection by Inducing Vascular Endothelial Growth Factor.

Busceti CL, Di Menna L, Bianchi F, Mastroiacovo F, Di Pietro P, Traficante A, Bozza G, Niehrs C, Battaglia G, Bruno V, Fornai F, Volpe M, Rubattu S, Nicoletti F.

Front Cell Neurosci. 2018 Sep 11;12:292. doi: 10.3389/fncel.2018.00292. eCollection 2018.

19.

mGlu1 Receptors Monopolize the Synaptic Control of Cerebellar Purkinje Cells by Epigenetically Down-Regulating mGlu5 Receptors.

Notartomaso S, Nakao H, Mascio G, Scarselli P, Cannella M, Zappulla C, Madonna M, Motolese M, Gradini R, Liberatore F, Zonta M, Carmignoto G, Battaglia G, Bruno V, Watanabe M, Aiba A, Nicoletti F.

Sci Rep. 2018 Sep 6;8(1):13361. doi: 10.1038/s41598-018-31369-7.

20.

Different generations of type-B monoamine oxidase inhibitors in Parkinson's disease: from bench to bedside.

Alborghetti M, Nicoletti F.

Curr Neuropharmacol. 2018 Aug 29. doi: 10.2174/1570159X16666180830100754. [Epub ahead of print]

PMID:
30160213

Supplemental Content

Loading ...
Support Center